Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
Go back to Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED| Labranche & Co (NASDAQ: LAB) | Delayed: 0.69 +0.02 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $4.47 | |||
| Open | $0.68 | 52 Week Low | $3.02 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $-1.56 | |||
| Volume | 652,207 | |||||



